Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia
Индуцированный стромальными клетками эпителиально-мезенхимальный переход вызывает поддающуюся таргетной терапии лекарственную устойчивость при остром лимфобластном лейкозе
2023-07-01
SCID: 54.1/vwscudt6
Discuss with AI
WNT/β-catenin signalingacute lymphoblastic leukemiadrug resistanceepithelial-mesenchymal transitionmesenchymal stem cells
Figures from the paper
Abstract (AI)
The bone marrow microenvironment (BME) drives drug resistance in acute lymphoblastic leukemia (ALL) through leukemic cell interactions with bone marrow (BM) niches, but the underlying mechanisms remain unclear. Here, we show that the interaction between ALL and mesenchymal stem cells (MSCs) through integrin β1 induces an epithelial-mesenchymal transition (EMT)-like program in MSC-adherent ALL cells, resulting in drug resistance and enhanced survival. Moreover, single-cell RNA sequencing analysis of ALL-MSC co-culture identifies a hybrid cluster of MSC-adherent ALL cells expressing both B-ALL and MSC signature genes, orchestrated by a WNT/β-catenin-mediated EMT-like program. Blockade of interaction between β-catenin and CREB binding protein impairs the survival and drug resistance of MSC-adherent ALL cells in vitro and results in a reduction in leukemic burden in vivo. Targeting of this WNT/β-catenin-mediated EMT-like program is a potential therapeutic approach to overcome cell extrinsically acquired drug resistance in ALL.
Key Findings
1
Blocking the interaction between β-catenin and CREB-binding protein reduced survival and drug resistance in vitro and decreased leukemic burden in vivo.
2
Interactions between acute lymphoblastic leukemia cells and mesenchymal stem cells through integrin β1 induce an EMT-like program in adherent leukemia cells.
3
Single-cell RNA sequencing identified a hybrid MSC-adherent leukemia-cell cluster expressing both B-ALL and MSC signature genes, regulated by WNT/β-catenin signaling.
4
Targeting the WNT/β-catenin-mediated EMT-like program may overcome microenvironmentally acquired drug resistance in acute lymphoblastic leukemia.
5
The MSC-induced EMT-like state enhances leukemia-cell survival and causes resistance to anticancer drugs.
Research Object
mesenchymal stem cell-adherent acute lymphoblastic leukemia cells in the bone marrow microenvironment
Research Subject
the integrin β1- and WNT/β-catenin-mediated EMT-like program underlying acquired drug resistance and enhanced survival
Publication Details
Publication Date
2023-07-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest